Estelle Marrer-Berger

4PUBLICATIONS
22CO-AUTHORS
Haematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 17, 2026
Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

|May 21, 2024
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody.

Sara Belli, Maria Amann, Lucy Hutchinson

|Jun 24, 2021
Cytokine Release Syndrome By T-cell-Redirecting Therapies: Can We Predict and Modulate Patient Risk?

Arthur J Van De Vyver, Estelle Marrer-Berger, Ken Wang

|Oct 10, 2017
Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment.

Frank R Brennan, Joy Cavagnaro, Kathleen McKeever

Pageof 1

Frequent Collaborators

2 joint publications

Sara Belli

1 joint publications

Kathleen McKeever

1 joint publications

Arthur J Van De Vyver

1 joint publications

Antje-Christine Walz